200 related articles for article (PubMed ID: 6098935)
21. Polio antibody outfit of newborns and infants born after 20 years of mass vaccination with live poliovaccine.
Koza J; Matyásová I; Danes L; Skovránek V; Havelková M
J Hyg Epidemiol Microbiol Immunol; 1984; 28(1):25-32. PubMed ID: 6325534
[TBL] [Abstract][Full Text] [Related]
22. [Observations on immune persistence after vaccination with attenuated polio vaccine (author's transl)].
Shi OS
Zhonghua Yu Fang Yi Xue Za Zhi; 1981 May; 15(3):148-50. PubMed ID: 7307827
[No Abstract] [Full Text] [Related]
23. 1,25-dihydroxyvitamin d3 enhances systemic and mucosal immune responses to inactivated poliovirus vaccine in mice.
Ivanov AP; Dragunsky EM; Chumakov KM
J Infect Dis; 2006 Feb; 193(4):598-600. PubMed ID: 16425140
[TBL] [Abstract][Full Text] [Related]
24. Progress with inactivated poliovirus vaccines derived from the Sabin strains.
Doi Y; Abe S; Yamamoto H; Horie H; Ohyama H; Satoh K; Tano Y; Ota Y; Miyazawa M; Wakabayashi K; Hashizume S
Dev Biol (Basel); 2001; 105():163-9. PubMed ID: 11763324
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of poliovirus neutralizing antibodies in young adult women.
Mayer TR; Balfour HH
JAMA; 1981 Sep; 246(11):1207-9. PubMed ID: 6267329
[No Abstract] [Full Text] [Related]
26. Safety and immunogenicity of a booster dose of inactivated poliovirus vaccine produced in vero-cells.
Haastrup E; Thierry-Carstensen B; Jensen AM; Stellfeld M; Heilmann C
Vaccine; 2004 Feb; 22(8):958-62. PubMed ID: 15161072
[TBL] [Abstract][Full Text] [Related]
27. [Findings of virus-neutralizing antibodies against polioviruses in the population of Slovakia 9 and 12 years following introduction of immunization by attenuated polioviruses (author's transl)].
Borská K; Mayerová A; Masár I; Svanigová L; Roda J; Lukácová V
Bratisl Lek Listy; 1976 Apr; 65(4):400-6. PubMed ID: 183864
[No Abstract] [Full Text] [Related]
28. [Behaviour and properties of poliomyelitis coproantibodies using the "antiglobin test" and the conventional neutralisation test (author's transl)].
Albano A; De Donato S; Scarinci V; Jakschik M
Zentralbl Bakteriol Orig A; 1974 Feb; 226(1):1-11. PubMed ID: 4152333
[No Abstract] [Full Text] [Related]
29. Decision analysis in planning for a polio outbreak in the United States.
Jenkins PC; Modlin JF
Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
[TBL] [Abstract][Full Text] [Related]
30. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.
Swartz TA; Green MS; Handscher R; Sofer D; Cohen-Dar M; Shohat T; Habib S; Barak E; Dror Z; Somekh E; Peled-Leviathan T; Yulzari R; Libling A; Mendelson E; Shulman LM
Vaccine; 2008 Feb; 26(8):1083-90. PubMed ID: 18241962
[TBL] [Abstract][Full Text] [Related]
31. [The use of immunomodulators to enhance postvaccinal immunity to experimental poliomyelitis].
Bondarenko VI; Zadorozhnaia VI; Buraia TA; Gritsenko LN
Mikrobiol Z; 1995; 57(6):41-5. PubMed ID: 8714398
[TBL] [Abstract][Full Text] [Related]
32. Seroimmunity to poliomyelitis in hospital personnel.
Tang RB; Wang HC; Lee SJ; Chang TK; Hwang B
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1984 Nov; 17(4):188-92. PubMed ID: 6099791
[TBL] [Abstract][Full Text] [Related]
33. [Antibodies against poliovirus in students of a Dutch Reformed school community following the 1978 epidemic].
Schaap GJ; Bijkerk H
Ned Tijdschr Geneeskd; 1981 Jan; 125(5):175-81. PubMed ID: 7207667
[No Abstract] [Full Text] [Related]
34. Comparison of the immune response of the rabbit to virulent and attenuated strains of type 1 poliovirus.
Gaudin OG; Viac J; Thouvenot D; Sohier R
Bull World Health Organ; 1974; 50(6):479-5. PubMed ID: 4376464
[TBL] [Abstract][Full Text] [Related]
35. Experience of vaccination with inactivated poliomyelitis vaccines in Iceland.
Gudnadóttir M
Dev Biol Stand; 1981; 47():257-9. PubMed ID: 7227654
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of an enzyme-linked immunosorbent assay based on binding inhibition for type-specific quantification of poliovirus neutralization-relevant antibodies.
Hashido M; Horie H; Abe S; Doi Y; Hashizume S; Agboatwalla M; Isomura S; Nishio O; Hagiwara A; Inouye S
Microbiol Immunol; 1999; 43(1):73-7. PubMed ID: 10100750
[TBL] [Abstract][Full Text] [Related]
37. Poliomyelitis vaccines: an appraisal after 25 years.
Melnick JL
Compr Ther; 1980 Jan; 6(1):6-14. PubMed ID: 7357844
[No Abstract] [Full Text] [Related]
38. [Antibody response to live trivaccine against poliomyelitis in adults].
Koza J; Skocil V; Matyásová I; Bruj J
Cesk Epidemiol Mikrobiol Imunol; 1984 Jul; 33(4):232-6. PubMed ID: 6091925
[No Abstract] [Full Text] [Related]
39. Absence of humoral immunity to poliovirus in vaccinated individuals.
Beuen K; White R; Kobayashi R; Farrell C
Nebr Med J; 1988 Feb; 73(2):40-4. PubMed ID: 2832773
[No Abstract] [Full Text] [Related]
40. Quantitation of poliovirus antigens in inactivated viral vaccines by enzyme-linked immunosorbent assay using animal sera and monoclonal antibodies.
Singer C; Knauert F; Bushar G; Klutch M; Lundquist R; Quinnan GV
J Biol Stand; 1989 Apr; 17(2):137-50. PubMed ID: 2541133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
